Literature DB >> 23917849

Outcome predictors for status epilepticus--what really counts.

Raoul Sutter1, Peter W Kaplan, Stephan Rüegg.   

Abstract

In adult patients with status epilepticus (SE)-a life-threatening state of ongoing or repetitive seizures--the current evidence regarding outcome prediction is based on clinical, biochemical and EEG determinants. These predictors of outcome involve clinical features such as age, history of prior seizures or epilepsy, SE aetiology, level of consciousness, and seizure type at SE onset. The clinical risk-benefit calculation between the danger of undertreated persistent seizure activity and, conversely, the potential damage from unwarranted aggressive treatments remains a constant challenge. Improved knowledge of outcome determinants, as well as increased availability of reliable outcome prediction models early in the course of SE, is paramount for optimization of treatment of patients who develop this disorder. In this Review, we discuss the major prognostic determinants of outcome in SE. Through consideration of studies that provide measures of association between predictors of SE outcome and death, we propose a detailed--but as yet unvalidated--paradigm for assessment of these predictors during the course of SE. Such an algorithm could guide the organization of results from existing trials and provide direction with regard to the parameters that should be monitored in future studies of SE.

Entities:  

Mesh:

Year:  2013        PMID: 23917849     DOI: 10.1038/nrneurol.2013.154

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  99 in total

1.  Hemodynamic changes during thiopental anesthesia in humans: cardiac output, stroke volume, total peripheral resistance, and intrathoracic blood volume.

Authors:  B ETSTEN; T H LI
Journal:  J Clin Invest       Date:  1955-03       Impact factor: 14.808

2.  Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.

Authors:  Christa B Swisher; Meghana Doreswamy; Krista J Gingrich; James J Vredenburgh; Brad J Kolls
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

Review 3.  Propofol versus thiopental sodium for the treatment of refractory status epilepticus.

Authors:  Hemanshu Prabhakar; Ashish Bindra; Gyaninder Pal Singh; Mani Kalaivani
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

4.  Treatment deviating from guidelines does not influence status epilepticus prognosis.

Authors:  Andrea O Rossetti; Vincent Alvarez; Jean-Marie Januel; Bernard Burnand
Journal:  J Neurol       Date:  2012-08-17       Impact factor: 4.849

5.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

6.  MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus.

Authors:  T Salmenperä; R Kälviäinen; K Partanen; E Mervaala; A Pitkänen
Journal:  Epilepsy Res       Date:  2000-07       Impact factor: 3.045

7.  Status epilepticus at an urban public hospital in the 1980s.

Authors:  D H Lowenstein; B K Alldredge
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

8.  Status epilepticus in children, adults, and the elderly.

Authors:  R J DeLorenzo; A R Towne; J M Pellock; D Ko
Journal:  Epilepsia       Date:  1992       Impact factor: 5.864

9.  Refractory status epilepticus: a prospective observational study.

Authors:  Jan Novy; Giancarlo Logroscino; Andrea O Rossetti
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

10.  Status epilepticus: an independent outcome predictor after cerebral anoxia.

Authors:  A O Rossetti; G Logroscino; L Liaudet; C Ruffieux; V Ribordy; M D Schaller; P A Despland; M Oddo
Journal:  Neurology       Date:  2007-07-17       Impact factor: 9.910

View more
  32 in total

Review 1.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

2.  Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients.

Authors:  Chloe E Hill; Leah J Blank; Dylan Thibault; Kathryn A Davis; Nabila Dahodwala; Brian Litt; Allison W Willis
Journal:  Neurology       Date:  2018-11-30       Impact factor: 9.910

3.  Electroclinical progression of subtle generalized convulsive status epilepticus: description of a case.

Authors:  José L Fernández-Torre; Eloy Rodríguez-Rodríguez; José L Vázquez-Higuera; Miguel A Hernández-Hernández
Journal:  J Neurol       Date:  2013-10-23       Impact factor: 4.849

4.  Intravenous Corticosteroids as an Adjunctive Treatment for Refractory and Super-Refractory Status Epilepticus: An Observational Cohort Study.

Authors:  Vasiliki Pantazou; Jan Novy; Andrea O Rossetti
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

5.  Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Authors:  Saskia Semmlack; Sarah Tschudin-Sutter; Andreas F Widmer; Martina Valença; Stephan Rüegg; Stephan Marsch; Raoul Sutter
Journal:  J Neurol       Date:  2016-05-03       Impact factor: 4.849

6.  Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study.

Authors:  Raoul Sutter; Gian Marco De Marchis; Saskia Semmlack; Peter Fuhr; Stephan Rüegg; Stephan Marsch; Wendy C Ziai; Peter W Kaplan
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

7.  Mortality prediction in status epilepticus with the APACHE II score.

Authors:  Jocelyn Y Cheng
Journal:  J Intensive Care Soc       Date:  2017-06-26

8.  Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.

Authors:  Vincent Alvarez; Jong Woo Lee; Frank W Drislane; M Brandon Westover; Jan Novy; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Epilepsia       Date:  2015-07-03       Impact factor: 5.864

Review 9.  Timing is everything: Where status epilepticus treatment fails.

Authors:  Chloe E Hill; Alomi O Parikh; Colin Ellis; Jennifer S Myers; Brian Litt
Journal:  Ann Neurol       Date:  2017-07-29       Impact factor: 10.422

Review 10.  Nonconvulsive status epilepticus in adults - insights into the invisible.

Authors:  Raoul Sutter; Saskia Semmlack; Peter W Kaplan
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.